Brind.
  1. Funeral services connect urban spiritual centers to suburban operational bases.
  2. Tim Hall leads a company that is expanding its operational presence in the state of Wisconsin.

Vector Science and Therapeutics Corp. Approves Stock Option Grant

1 report, 1 independent Updated Sep 1
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Vector Science and Therapeutics Corp. announced that its Board of Directors approved the grant of 150,000 stock options to an Officer. These options have an exercise price of C$1.80 and vest in 25% tranches over a three-year period. The company, headquartered in Mequon, Wisconsin, develops novel biomechanical devices and active localized drug delivery platforms.

From finanznachrichten.de

Why it matters

Some supportBrind's analysis of the reports

The stock option grant affects the capital structure of Vector Science and Therapeutics Corp. The company is listed on the TSX Venture Exchange under the symbol PAIN.

Tim Hall leads a company that is expanding its operational presence in Wisconsin. Funeral services connect urban spiritual centers to suburban operational bases.

From finanznachrichten.de

Who's involved

  • companyVector Science and Therapeutics Corp., the company that approved the stock option grant
  • Tim HallLeads a company that is expanding its operational presence in Wisconsin

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • companySpeculative

    Vector Science and Therapeutics Corp. might see changes in its capital structure due to the stock option grant.

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped